Cloning and characterization of ginsenoside Ra1-hydrolyzing beta-D-xylosidase from Bifidobacterium breve K-110.

J Microbiol Biotechnol

Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University, Seoul 130-701, Korea.

Published: April 2012

AI Article Synopsis

  • beta-D-Xylosidase (XlyBK-110) from Bifidobacterium breve K-110 was cloned and expressed in E. coli, achieving high purification yields using Ni²⁺-affinity chromatography.
  • The enzyme has a molecular mass of 55.7 kDa and shows significant similarity to a glycosyl hydrolase from Bifidobacterium adolescentis, with an optimal pH of 6.0 and temperature of 45°C.
  • This study is the first to report the cloning and functional expression of this enzyme capable of hydrolyzing ginsenoside Ra1 and kakkalide from human intestinal microflora.

Article Abstract

beta-D-Xylosidase (E.C. 3.2.1.37) from Bifidobacterium breve K-110, which hydrolyzes ginsenoside Ra1 to ginsenoside Rb2, was cloned and expressed in Escherichia coli. The (His6)-tagged recombinant enzyme, designated as XlyBK- 110, was efficiently purified using Ni²⁺-affinity chromatography (109.9-fold, 84% yield). The molecular mass of XylBK- 100 was found to be 55.7 kDa by SDS-PAGE. Its sequence revealed a 1,347 bp open reading frame (ORF) encoding a protein containing 448 amino acids, which showed 82% identity (DNA) to the previously reported glycosyl hydrolase family 30 of Bifidobacterium adolescentis ATCC 15703. The Km and Vmax values toward p-nitrophenyl-beta-D-xylopyranoside (pNPX) were 1.45mM and 10.75 micromol/min/mg, respectively. This enzyme had pH and temperature optima at 6.0 and 45 degrees C, respectively. XylBK-110 acted to the greatest extent on xyloglucosyl kakkalide, followed by pNPX and ginsenoside Ra1, but did not act on p-nitrophenyl-alpha-Larabinofuranoside, p-nitrophenyl-beta-D-glucopyranoside, or p-nitrophenyl-beta-D-fucopyranoside. In conclusion, this is the first report on the cloning and expression of beta-Dxylosidase- hydrolyzing ginsenoside Ra1 and kakkalide from human intestinal microflora.

Download full-text PDF

Source
http://dx.doi.org/10.4014/jmb.1110.10001DOI Listing

Publication Analysis

Top Keywords

ginsenoside ra1
12
bifidobacterium breve
8
breve k-110
8
ginsenoside
5
cloning characterization
4
characterization ginsenoside
4
ginsenoside ra1-hydrolyzing
4
ra1-hydrolyzing beta-d-xylosidase
4
beta-d-xylosidase bifidobacterium
4
k-110 beta-d-xylosidase
4

Similar Publications

Three-dimensional characteristic chromatogram by online comprehensive two-dimensional liquid chromatography: Application to the identification and differentiation of ginseng from herbal medicines to various Chinese patent medicines.

J Chromatogr A

July 2023

State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin, 301617, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin, 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin, 301617, China. Electronic address:

One bottleneck problem in the quality control of traditional Chinese medicine (TCM) is the accurate identification of easily confused herbal medicines from Chinese patent medicine (CPM). Ginseng products derived from the multiple parts (e.g.

View Article and Find Full Text PDF

Introduction: Doxorubicin-induced cardiotoxicity (DIC) is a serious obstacle to oncologic treatment. Mountain cultivated ginseng (MCG) exhibits stronger pharmacological effects than cultivated ginseng (CG) mainly due to the differences in ginsenosides. However, the material basis and the underlying mechanism of the protective effects of total saponins of MCG (TSMCG) against DIC are unclear.

View Article and Find Full Text PDF

As the health food industry grows, the market for ginseng also expands globally. Korean ginseng (Panax ginseng C. A.

View Article and Find Full Text PDF

Simultaneous quantification of twenty-eight components of Shenfu Injection in rat plasma by UHPLC-QQQ MS and its application to a pharmacokinetic study.

J Pharm Biomed Anal

September 2021

State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China. Electronic address:

Shenfu Injection (SFI), derived from the classical traditional Chinese medicine formula "Shenfu Decoction", is a modern preparation used to treat heart failure and shock in clinic. In this study, an ultra-high performance liquid chromatography-triple quadruple tandem mass spectrometry (UHPLC-QQQ MS) method was established to simultaneously quantify twenty-eight main active components of SFI in rat plasma, including eighteen ginsenosides and ten aconite alkaloids. Multi-reaction monitoring in positive and negative ionization switching modes is used for mass spectrometry analysis, and the whole analysis process was within 14 min.

View Article and Find Full Text PDF

Panax ginseng C. A. Mey (PGCAM) is a herbaceous perennial belonging to the family, mainly including Mountain-Cultivated Ginseng (MCG) and Garden Ginseng (GG) on the market.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!